Researchers have found that a new immunotherapy combination may help restore immune function in critically ill patients suffering from severe lung infections. The treatment pairs agenT-797, an investigational cell therapy, with N-803, an FDA-approved drug. This sequential therapy showed promise in a patient with a severe fungal infection and pneumonia who had not responded to standard treatments.

For people concerned about their health, especially those interested in how to support their immune system as they age, this finding is significant. The combination therapy led to the suppression of both fungal and bacterial infections, improved immune cell activity in the lungs, and activated tissue repair processes. While this was a single case study, it suggests that restoring immune function could be crucial for patients facing severe respiratory issues, which is particularly relevant as we age and our immune systems may weaken.

The evidence comes from a clinical case presented at a major medical conference and published in a scientific journal. While this study is early-stage and involves just one patient, it highlights a potential new approach to treating severe lung infections and respiratory failure. The researchers are now planning larger trials to better understand how this treatment can help critically ill patients.

If you’re interested in supporting your immune health, consider discussing with your healthcare provider about ways to enhance your immune function through lifestyle changes, such as a balanced diet, regular exercise, and stress management. These foundational practices can complement emerging therapies and help you maintain better health as you age.

Source: globenewswire.com